Neptune Medical, a Burlingame, CA-based leader in medical device innovation, announced theì spinout of its subsidiary, Jupiter Endovascular, following the completion of a $97m Series D financing
Neptune Medical, a Burlingame, CA-based leader in medical device innovation, announced theì spinout of its subsidiary, Jupiter Endovascular, following the completion of a $97m Series D financing
Neptune Medical, a pioneering company in the medical device industry, has successfully raised $97 million in a Series D financing round. This latest funding round was led by major investors who recognize the potential of Neptune’s innovative technology in transforming medical procedures.
The company, known for its proprietary Dynamic Rigidization™ technology, develops advanced medical devices that enhance flexibility and control during endoscopic and minimally invasive procedures. This technology represents a significant leap forward in the field, allowing for greater precision and safety in complex surgeries.
Neptune Medical plans to use the newly raised funds to accelerate the development and commercialization of its current and upcoming products. The investment will also support the company's efforts to expand its market presence, particularly in the U.S. and international markets. Additionally, the funding will enable further research and development to enhance their existing technology and explore new applications.
Founded by an experienced team with deep roots in medical technology, Neptune Medical has quickly become a significant player in the industry. The company's leadership includes veterans from top medical device companies, bringing a wealth of expertise and a clear vision for the future of surgical technology.
The $97 million investment marks a critical milestone for Neptune Medical, positioning it to scale its operations and make a broader impact on the healthcare sector. As the demand for less invasive surgical options continues to grow, Neptune's technology is expected to play a crucial role in meeting this need, offering solutions that improve patient outcomes and streamline surgical procedures.
This funding round is also indicative of the growing interest in innovative medical technologies among investors, reflecting a broader trend in the industry. With the backing of its new investors, Neptune Medical is well-positioned to lead the next wave of advancements in minimally invasive surgery, further solidifying its status as a key innovator in the medical device space.
Neptune Medical, a Burlingame, CA-based leader in medical device innovation, announced theì spinout of its subsidiary, Jupiter Endovascular, following the completion of a $97m Series D financing